Source: Eur Respir J 2013; 41: 706-715
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Pantazopoulos Ioannis, Boura Paraskevi, Xanthos Theodoros, Syrigos Konstantinos. Effectiveness of mesothelin family proteins and osteopontin for malignant mesothelioma. Eur Respir J 2013; 41: 706-715

Member's Comments

No comment yet.

Related content which might interest you: Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma Source: Annual Congress 2008 - Inorganic dust exposure and the lung Year: 2008 A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma Source: Eur Respir J 2010; 36: 1099-1105 Year: 2010 ADAM10 membrane-bound protease mediates malignant pleural mesothelioma invasiveness Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018 Soluble mesothelin as a monitoring tool for malignant mesothelioma patients Source: Annual Congress 2009 - New insights in biology and treatment of pleural tumours Year: 2009 Identification of differentially expressed proteins in human malignant pleural effusions Source: Eur Respir J 2006; 28: 1178-1185 Year: 2006 Tumor-derived monocyte chemoattractant protein-1 promotes malignant pleural effusion Source: Eur Respir J 2007; 30: Suppl. 51, 290s Year: 2007 Utility of serum soluble mesothelin as a follow-up marker in patients with malignant pleural mesothelioma Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007 Increased expression of angiogenic growth factor stromal cell derived factor-1 (SDF-1/CXCL12) in pleural fluid of patients with lung cancer: preliminary results Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 LSC - 2018 - Tumor-derived granulocyte chemotactic protein 2 cooperates with neutrophil proteinase 3 to drive lung adenocarcinoma Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018 Elevated serum B cell activating factor belonging to the TNF family (BAFF) in interstitial lung diseases associated with collagen vascular disease Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 Late Breaking Abstract - Decreased thrombospondin-1 and bone morphogenetic protein-4 serum levels in non-small-cell lung cancer and the relationship of these proteins with the stage of the disease. Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017 Loss of polymeric immunoglobulin receptor expression is associated with lung tumourigenesis Source: Eur Respir J 2012; 39: 1171-1180 Year: 2012 The metallopeptidase neprilysin is a hypoxia-induced prognostic factor in lung adenocarcinoma Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Expression of tumor necrosis factor receptor 2 in human non-small cell lung cancer and its role as a potential prognostic biomarker Source: International Congress 2019 – Biology of lung cancer Year: 2019 Some of the tumor necrosis factor receptor superfamilies and their concentrations in serum during chemotherapy of lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 102s Year: 2006 Monocyte chemotactic protein-1 stimulates lung cancer cells proliferation Source: Annual Congress 2007 - Biology in thoracic oncology Year: 2007 RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer Source: Eur Respir J 2012; 39: 677-684 Year: 2012 Enhanced expression of insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-6 in bronchoalveolar lavage cells from patients with sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 410s Year: 2001 Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer Source: Eur Respir J 2007; 30: 627-632 Year: 2007 KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts Source: Eur Respir J 2006; 28: Suppl. 50, 340s Year: 2006